Skip to main content

Study

Probiotic Supplements Enhance Flu Vaccine Response in Seniors

Taking a specific probiotic daily improved flu vaccine effectiveness in seniors by boosting immune responses.

Study Credibility: High8.1/10From a trusted journalProperly designed studyResults verified
PublishedOct 2026Last reviewedOct 2026
Email this

Summary

In plain language

Recent research has found that a specific probiotic, known as Lactobacillus coryniformis K8, can enhance the effectiveness of the flu vaccine in older adults. In a study involving seniors living in nursing homes, those who took a daily probiotic capsule had a stronger immune response to the flu vaccine compared to those who did not. Specifically, 93.1% of seniors taking the probiotic showed improved antibody levels, compared to 72.7% in the control group. This finding is important because flu vaccines tend to be less effective in older adults. Discussing probiotic supplements with a healthcare provider might be beneficial, especially during flu season.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study was a randomized, controlled trial involving seniors over 65 in nursing homes. Participants were divided into two groups: one took a probiotic supplement daily, while the other took a placebo. After receiving the flu vaccine, the probiotic group showed a 93.1% improvement in immune response, compared to 72.7% in the placebo group.

  • The study used a double-blind design, meaning neither participants nor researchers knew who received the probiotic or the placebo.

  • While the probiotic improved vaccine response, it did not significantly reduce flu-like illness symptoms during the study period.

  • As the study was conducted in a specific setting, results may vary in different environments or populations.

Seniors should consider discussing the potential benefits of probiotics with their healthcare providers, especially during flu season.

Research Quality Score

Scored October 22, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study scores highly due to its rigorous randomized controlled trial design, strong bias control, and comprehensive reporting. However, the lack of journal information affects the journal quality score, and potential conflicts of interest due to industry involvement lower the conflicts score. The study is directly relevant to the target population of seniors.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control10.0/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding5.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

The study evaluates the effect of Lactobacillus coryniformis K8 on enhancing the immune response to the influenza vaccine in seniors. It finds increased seroconversion rates and reduced respiratory symptoms in the probiotic group compared to placebo.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.